StarZero All shows Try the podcast clipper →

cerebral cavernous malformation

1 statements across 1 episodes · 1 bullish · 0 bearish · 1 people on the record · first statement Apr 17, 2017 by Chris Gibson · across every show →

Everything said about cerebral cavernous malformation, oldest first

Apr 17, 2017 positive
Disclosure
Gibson: Recursion is eight months from clinical trials for CCM
“We also have an internal pipeline of drugs that we're developing ourselves one of those is just about eight months away from clinical trials now for a disease called cerebral cavernous malformation.”
Chris Gibson Apr 17, 2017 ▶ 4:20 632: Recursion enzyme company raises $23M, launched in 2013 now 40 people with drugs ready for market with CEO Christopher Gibson
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 2,600 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more